This HTML5 document contains 137 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
n11http://dx.doi.org/10.1200/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q33376149
rdf:type
wikibase:Item
schema:description
vetenskaplig artikel 2007年論文 articolo scientifico ২০০৭-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ სამეცნიერო სტატია 2007年論文 2007 թվականի օգոստոսին հրատարակված գիտական հոդված 2007年论文 научни чланак 2007年论文 wissenschaftlicher Artikel artikulong pang-agham artigo científico (publicado na 2007) 2007년 논문 2007年论文 wetenschappelijk artikel artigo científico (publicado na 2007) naučni članak سائنسی مضمون bilimsel makale επιστημονικό άρθρο мақолаи илмӣ 2007年の論文 научная статья mokslinis straipsnis tieteellinen artikkeli artykuł naukowy 2007年論文 2007年论文 vitskapeleg artikkel scienca artikolo мақолаи илмӣ artikull shkencor bài báo khoa học articol științific 2007 nî lūn-bûn научни чланак artículo científico publicado en 2007 vedecký článok artículu científicu espublizáu en 2007 2007年論文 научна статия article scientific บทความทางวิทยาศาสตร์ artigo científico 2007 թուականի Օգոստոսին հրատարակուած գիտական յօդուած article scientifique (publié 2007) scientific article 2007年论文 2007年論文 vitenskapelig artikkel מאמר מדעי 2007年论文 teaduslik artikkel videnskabelig artikel (udgivet 2007) مقالهٔ علمی مقالة علمية article científic tudományos cikk наукова стаття, опублікована в серпні 2007 vědecký článek
p:P577
wds:Q33376149-08249794-41E4-4BBC-8BA3-410CC8EDEF54
wdt:P577
2007-08-06T00:00:00Z
p:P407
wds:Q33376149-F902A878-86C4-4C8E-B3D1-B3BF473016BE
wdt:P407
wd:Q1860
p:P2093
wds:Q33376149-BE6F4C33-65D6-4F0F-9506-CE94F54E4433 wds:Q33376149-D054F825-62FE-4A12-BB37-F698D50C14BC wds:Q33376149-AF33B034-B70D-4D1E-999D-8D3C7FC9180E wds:Q33376149-BC97A909-41F1-4DCA-A0E3-137B412300C4 wds:Q33376149-AA870DFB-3C66-4D4F-8445-C281B6F91D35 wds:Q33376149-FA6C24C5-B0F5-444E-BE50-071D3DC88FBE wds:Q33376149-61F41A02-8FFE-48A5-9ABE-E71022B74B24 wds:Q33376149-4BF5373E-F9D2-48CF-B7F8-24518B54E9C0 wds:Q33376149-3D8E5C57-5E27-49FA-8E8B-82AFD308BFE8 wds:Q33376149-1CC5AB14-ADA3-4100-B302-6E03E9A90CDC wds:Q33376149-28F2E679-8D70-4EA1-B175-8C5AFC81D886 wds:Q33376149-96D6D10A-81BF-484B-ABFB-53EDECE8CC1F wds:Q33376149-9C3EA7A0-35D9-4414-BAF2-BAC5ADE24ACB wds:Q33376149-861C22AD-8536-4ACD-8E00-05FF561DA561
wdt:P2093
Jean-Luc Harousseau Trilok Parekh Zhilong Yuan Sen H Zhuang Arnon Nagler Roman Hajek Heather J Sutherland Wayne Rackoff Jesús San Miguel Andrew Spencer Joan Bladé Noemi Horvath Alexander N Suvorov Liang Xiu
rdfs:label
Randomized phase III study of pegylated liposomal doxorubicin plus bortezomib compared with bortezomib alone in relapsed or refractory multiple myeloma: combination therapy improves time to progression Randomized phase III study of pegylated liposomal doxorubicin plus bortezomib compared with bortezomib alone in relapsed or refractory multiple myeloma: combination therapy improves time to progression Randomized phase III study of pegylated liposomal doxorubicin plus bortezomib compared with bortezomib alone in relapsed or refractory multiple myeloma: combination therapy improves time to progression
skos:prefLabel
Randomized phase III study of pegylated liposomal doxorubicin plus bortezomib compared with bortezomib alone in relapsed or refractory multiple myeloma: combination therapy improves time to progression Randomized phase III study of pegylated liposomal doxorubicin plus bortezomib compared with bortezomib alone in relapsed or refractory multiple myeloma: combination therapy improves time to progression Randomized phase III study of pegylated liposomal doxorubicin plus bortezomib compared with bortezomib alone in relapsed or refractory multiple myeloma: combination therapy improves time to progression
schema:name
Randomized phase III study of pegylated liposomal doxorubicin plus bortezomib compared with bortezomib alone in relapsed or refractory multiple myeloma: combination therapy improves time to progression Randomized phase III study of pegylated liposomal doxorubicin plus bortezomib compared with bortezomib alone in relapsed or refractory multiple myeloma: combination therapy improves time to progression Randomized phase III study of pegylated liposomal doxorubicin plus bortezomib compared with bortezomib alone in relapsed or refractory multiple myeloma: combination therapy improves time to progression
p:P50
wds:Q33376149-D2E3475D-0FF7-4DF9-B754-06AD6EB90820 wds:Q33376149-D8A3962D-BAC3-437C-BEC8-20D277DC99F1 wds:Q33376149-87DF8FA2-CE4A-4BBB-8F56-1BE997FA0801 wds:Q33376149-5C545327-F4B7-4561-A182-C915852CBA60 wds:Q33376149-31BBF1E7-A54C-4905-8212-A847C37F44FE
wdt:P50
wd:Q87746991 wd:Q91428664 wd:Q54102681 wd:Q73546936 wd:Q62603971
p:P1476
wds:Q33376149-18DCA634-7B17-422D-8395-F109D0214E06
wdt:P1476
Randomized phase III study of pegylated liposomal doxorubicin plus bortezomib compared with bortezomib alone in relapsed or refractory multiple myeloma: combination therapy improves time to progression
p:P304
wds:Q33376149-50997601-B558-49AD-87D7-F2EE3DB4193B
wdt:P304
3892-3901
p:P31
wds:Q33376149-94892C5B-370A-4B19-89F3-62451817C6D3
wdt:P31
wd:Q13442814
p:P921
wds:Q33376149-0C494BD6-6B45-43C0-8AC4-A9B5955E7106 wds:Q33376149-E1DED742-76C1-4188-B9D8-7B4339BFA337
wdt:P921
wd:Q18936 wd:Q467635
p:P698
wds:Q33376149-157FC585-47B6-4C80-AD40-BF2C4D9173D0
wdtn:P698
n12:17679727
wdt:P698
17679727
p:P1433
wds:Q33376149-7103A0BE-5444-485B-9EAA-C0768476D738
wdt:P1433
wd:Q400292
p:P433
wds:Q33376149-01CC4FD4-BBE1-4108-BB3C-D430531858AC
p:P478
wds:Q33376149-67379712-B526-43B6-9F8F-C7343BF06332
wdt:P433
25
wdt:P478
25
p:P356
wds:Q33376149-858FA8F9-AA94-44D2-B5E9-F271FC70D208
wdtn:P356
n11:JCO.2006.10.5460
wdt:P356
10.1200/JCO.2006.10.5460
p:P8608
wds:Q33376149-ABDCE825-02E9-45BB-9566-72CEDAD06FCA
wdt:P8608
release_3uyytdfzgnalrgkucqyypt3nli